LICENSE AGREEMENT by and between SHANGHAI FOSUN PHARMACEUTICAL INDUSTRIAL DEVELOPMENT CO. LTD. and PALATIN TECHNOLOGIES, INC. September 6, 2017License Agreement • November 13th, 2017 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”) is entered into as of September 6, 2017 (the “Effective Date”), by and between Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., a limited liability company organized and existing under the laws of the People’s Republic of China and having a registered principal place of business at No. 1289 Yishan Road (Building A, Fosun Technology Park), Shanghai City, 200233, the People’s Republic of China (“Fosun”) and Palatin Technologies, Inc., a corporation organized and existing under the laws of Delaware and having a principal place of business at 4-B Cedar Brook Drive, Cedar Brook Corporate Center, Cranbury, NJ 08512 (“Palatin”). Fosun and Palatin may each be referred to herein individually as a “Party” and collectively as the “Parties.”
